King KE - Search Results

1

The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease.

Quirolo K, Bertolone S, Hassell K, Howard T, King KE, Rhodes DK, Bill J. Quirolo K, et al. Among authors: king ke. Transfusion. 2015 Apr;55(4):775-81. doi: 10.1111/trf.12891. Epub 2014 Oct 21. Transfusion. 2015. PMID: 25330984 Clinical Trial.

2

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Tormey CA, Peddinghaus ME, Erickson M, King KE, Cushing MM, Bill J, Goodrich T, Snyder EL. Tormey CA, et al. Among authors: king ke. Transfusion. 2010 Feb;50(2):471-7. doi: 10.1111/j.1537-2995.2009.02412.x. Epub 2009 Oct 5. Transfusion. 2010. PMID: 19804570 Clinical Trial.

3

Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA. Kacker S, et al. Among authors: king ke. Transfusion. 2014 Jan;54(1):86-97. doi: 10.1111/trf.12250. Epub 2013 May 21. Transfusion. 2014. PMID: 23692415 Free PMC article.

4

Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.

Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA. Kacker S, et al. Among authors: king ke. Transfusion. 2014 Aug;54(8):2034-44. doi: 10.1111/trf.12585. Epub 2014 Feb 27. Transfusion. 2014. PMID: 24571485 Free PMC article.

5

Red blood cell transfusion triggers in acute leukemia: a randomized pilot study.

DeZern AE, Williams K, Zahurak M, Hand W, Stephens RS, King KE, Frank SM, Ness PM. DeZern AE, et al. Among authors: king ke. Transfusion. 2016 Jul;56(7):1750-7. doi: 10.1111/trf.13658. Epub 2016 May 20. Transfusion. 2016. PMID: 27198129 Free PMC article. Clinical Trial.

6

Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.

King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM. King KE, et al. Transfusion. 1997 Apr;37(4):376-81. doi: 10.1046/j.1537-2995.1997.37497265337.x. Transfusion. 1997. PMID: 9111274

7

The future of red blood cell alloimmunization risk reduction.

Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AA. Kacker S, et al. Among authors: king ke. Transfusion. 2015 Jan;55(1):222-4. doi: 10.1111/trf.12866. Transfusion. 2015. PMID: 25582240 Free PMC article. No abstract available.

8

Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.

Buetens O, Shirey RS, Goble-Lee M, Houp J, Zachary A, King KE, Ness PM. Buetens O, et al. Among authors: king ke. Transfusion. 2006 May;46(5):754-6. doi: 10.1111/j.1537-2995.2006.00793.x. Transfusion. 2006. PMID: 16686842

9

Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction.

Tobian AA, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM. Tobian AA, et al. Among authors: king ke. Transfusion. 2011 Aug;51(8):1676-83. doi: 10.1111/j.1537-2995.2010.03008.x. Epub 2011 Jan 7. Transfusion. 2011. PMID: 21214585

10

The impact of apheresis platelet manipulation on corrected count increment.

Karafin M, Fuller AK, Savage WJ, King KE, Ness PM, Tobian AA. Karafin M, et al. Among authors: king ke. Transfusion. 2012 Jun;52(6):1221-7. doi: 10.1111/j.1537-2995.2011.03476.x. Epub 2012 Jan 10. Transfusion. 2012. PMID: 22233358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters